5 questions about NIH licenses to patents on Production of Attenuated Respiratory Syncytial Virus Vaccines
The NIH has a notice for comments on proposed licenses of several patents relating to the “Production of Attenuated Respiratory Syncytial Virus Vaccines”. See: https://federalregister.gov/a/2016-03486
We asked Peter Soukas, a Senior Technology Licensing Specialist in the Technology Transfer and Intellectual Property Office, at the National Institute of Allergy and Infectious Diseases (NIAID), these questions:
- What provisions exist in the license to protect US residents against excessive or unreasonable pricing?